Defining the Research Agenda for Antimicrobial Resistance
Project Details
The rapid global spread of “superbugs” causing infections not treatable with existing antimicrobial medicines such as antibiotics is alarming.
Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death.
World Health Organization (WHO) has developed a Global Action Plan (GAP) on AMR to better understand how resistance disseminates between humans, animals, plants, water, soils, and the air.
Nossal Institute is working with WHO Geneva to identify and prioritise a future research agenda where the health of humans, animals, plants and crops, and our wider environment (including soils, water, air) is considered holistically.
This project will develop a research agenda for One Health to effectively reduce AMR. Our research will identify research gaps in the One Health area of AMR at the intersection between human, animal, environment sectors.
We will identify 50 research activities that will give the greatest reduction of AMR, to ensure scarce research capacity and investment give maximum impact.
Our report of the One Health Priority Research Agenda is expected to be completed late 2022
Researchers
Dr Angus Campbell
Alison Macintyre
Dr Lindsey Gale
Daniel Strachan
Cormac Mercer
Collaborators
Dr Gillian Lê, Research Consultant
Professor Benjamin Howden, Doherty Applied Microbial Genomics
Professor Kirsty Buising National Centre for Antimicrobial Stewardship
Professor Linda Blackall Environmental Microbiology Research Centre in the School of BioSciences at the University of Melbourne
Professor Erica Donner is the Director of Industry Partnerships OUTBREAK consortium.
Dr Laura Hardefeldt National Centre for Antimicrobial Stewardship
Dr Kristen Smith, School of Population and Global Health, University of Melbourne
Funding
This research is funded by WHO
Research Outcomes
A One Health Priority Research Agenda for Antimicrobial Resistance